LifeStance Health Group LFST Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 3%+4.1pp | 1.7%+4.3pp | 0.4%+5.8pp | -0.1%+12.0pp | -1.1%+14.5pp | |
| Net margin | 1.6%+3.8pp | 0.7%+4.7pp | -0.7%+6.7pp | -0.7%+12.3pp | -2.3%+13.4pp | |
| EBITDA margin | 6.6%+2.9pp | 5.5%+2.5pp | 4.5%+3.4pp | 4.3%+9.1pp | 3.7%+11.7pp | |
| Free cash flow margin | 9.5%+1.6pp | 7.7%+0.9pp | 8.7%+6.3pp | 9.1%+11.1pp | 8%+14.7pp | |
| Returns | ||||||
| Return on equity | 1.6%+3.6pp | 0.7%+4.2pp | -0.6%+5.5pp | -0.7%+9.7pp | -2%+9.8pp | |
| Return on assets | 1.1%+2.5pp | 0.4%+2.8pp | -0.4%+3.7pp | -0.4%+6.6pp | -1.4%+6.7pp | |
| Return on invested capital | 1.7%+2.5pp | 1.1%+2.9pp | 0.3%+3.8pp | -0.1%+7.3pp | -0.8%+8.3pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×+0.1× | 0.7×+0.1× | 0.6×+0.1× | 0.6×+0.1× | 0.6×+0.1× | |
| Liquidity | ||||||
| Current ratio | 1.5×0.0× | 1.7×+0.3× | 1.6×+0.3× | 1.5×+0.3× | 1.5×+0.3× | |
| Quick ratio | 1.5×0.0× | 1.7×+0.3× | 1.6×+0.3× | 1.5×+0.3× | 1.5×+0.3× | |
| Cash ratio | 0.8×+0.2× | 1×+0.3× | 0.9×+0.4× | 0.8×+0.4× | 0.6×+0.4× | |
| Leverage | ||||||
| Debt-to-equity | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Debt-to-assets | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Net debt / EBITDA | 2.8×-4.4× | 2.9×-5.8× | 4.3×-24.2× | 5.1×— | 7.3×— | |
| Interest coverage | 4.3×+4.9× | 2.1×+3.3× | 0.3×+3.2× | -0.1×+6.1× | -0.6×+7.2× | |
| Per Share | ||||||
| Book value per share | $3.74+0.3% | $3.89+1.9% | $3.84+1.6% | $3.81+1.1% | $3.73-1.8% | |
| Valuation | ||||||
| Market capitalization | $2.44B-4.8% | $2.74B-2.9% | $2.14B-19.5% | $1.98B+6.9% | $2.56B+9.6% | |
| Enterprise value | $2.72B-6.5% | $2.96B-5.9% | $2.41B-20.8% | $2.26B+0.1% | $2.91B+4.1% | |
| Price / earnings | 105.1×— | 283.4×— | —— | —— | —— | |
| Price / sales | 1.6×-0.4× | 1.9×-0.3× | 1.6×-0.6× | 1.5×-0.1× | 2×-0.1× | |
| Price / book | 1.7×-0.1× | 1.8×-0.1× | 1.4×-0.4× | 1.3×0.0× | 1.8×+0.1× | |
| EV / EBITDA | 27.4×-33.4× | 37.6×-44.7× | 38.8×-186× | 40.2×— | 60.8×— | |
| EV / sales | 1.8×-0.4× | 2.1×-0.4× | 1.8×-0.8× | 1.7×-0.2× | 2.3×-0.3× | |
| Free cash flow yield | 5.8%+1.9pp | 4%+1.0pp | 5.6%+4.5pp | 6.1%+7.3pp | 4%+7.2pp | |
| Earnings yield | 1%+2.1pp | 0.4%+2.2pp | -0.4%+2.9pp | -0.5%+7.7pp | -1.1%+6.3pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do LifeStance Health Group's ratios come from?
- Every ratio is computed from LifeStance Health Group's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.